Need professional-grade analysis? Visit stockanalysis.com
$8.33M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Enlitic Inc (ENL) Price Performance
Enlitic Inc (ENL) trades on Australian Securities Exchange in AUD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at AUD0.01, up 11.11% from the previous close.
Over the past year, ENL has traded between a low of AUD0.01 and a high of AUD0.05. The stock has lost 79.2% over this period. It is currently 80.6% below its 52-week high.
Enlitic Inc has a market capitalization of $8.33M.
About Enlitic Inc
Enlitic, Inc. operates in the healthcare sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images. Its healthcare data solutions include ENDEX, a platform that uses AI to standardize new and historical medical image data descriptions; ENCOG, an AI enabled data anonymization solution designed to de-identify protected health information from medical imaging data; and Migratek, an AI-enabled data migration solution, as well as routing services. The company provides its solutions to radiologists, IT professionals, executives, and researchers; and training services to PACS administrators, IT supervisors, system administrators, radiologists, and technologists. The company was formerly known as You Partners, Inc. Enlitic, Inc. was incorporated in 2014 and is based in Loveland, Colorado.
Compare Enlitic Inc
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- Australian Securities Exchange
- Currency
- AUD
- Country
- Australia
Financial Metrics
- Revenue (TTM)
- $3.80M
- EBITDA
- $-12,707,180
- Profit Margin
- -349.07%
- EPS (TTM)
- -0.03
- Book Value
- 0.01
Technical Indicators
- 52 Week High
- A$0.05
- 52 Week Low
- A$0.01
- 50 Day MA
- A$0.01
- 200 Day MA
- A$0.02
- Beta
- -1.59
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- 2.19
- Price/Book
- 1.45
- Enterprise Value
- $5.97M